Rachael C Adams

9PUBLICATIONS
76CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Innate immunityCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 22, 2026
IL-6 receptor inhibition promotes expansion of cytolytic CD4+ T cells after cellular immunotherapy.

|Mar 02, 2026
CSF-1R inhibition and lenalidomide synergize to promote myeloma control after autologous stem cell transplantation.

Simone Minnie, Kenneth Ho, Julie R Boiko

|Jul 08, 2025
Gut microbiota-derived TMAVA is a modulator of acute CNS-GVHD.

Sangya Chatterjee, Tamina Rückert, Ina Martin

|Mar 31, 2025
AhR activation mitigates graft-versus-host disease of the central nervous system by reducing microglial NF-κB signaling.

Alexander Zähringer, Inês Morgado, Daniel Erny

|Nov 22, 2024
The contribution of the monocyte-macrophage lineage to immunotherapy outcomes.

Rachael C Adams, Kelli P A MacDonald, Geoffrey R Hill

|Dec 04, 2023
CSF1R inhibition promotes neuroinflammation and behavioral deficits during graft-versus-host disease in mice.

Rachael C Adams, Dylan Carter-Cusack, Genesis T Llanes

Pageof 2

Frequent Collaborators

3 joint publications

Janaki Manoja Vinnakota

2 joint publications

Behnam Rashidieh

2 joint publications

Murugan Kalimutho

2 joint publications

Kum Kum Khanna